知镜 Cognispect · 医学文献与研究工作台

Therapeutic response to ferric hydroxide versus ferrous glycine sulfate in pediatric autoimmune gastritis-related iron deficiency anemia.

Carvalho Queirós J, Martins IA, Lachado A, Ribeiro-Mourão F, Moreira-Silva H, Couto Guerra I, Tavares M, Costa E, Lima R.
Journal of pediatric gastroenterology and nutrition · 2026-09-07 · PMID 42706716

文献摘要

Objectives Autoimmune gastritis (AIG) is characterized by immune-mediated destruction of gastric parietal cells and impaired iron absorption. Refractory iron deficiency anemia (IDA) is often the main clinical presentation in pediatric patients. Because oral ferrous glycine sulfate (FGS) is absorbed independently of gastric pH, it may represent an effective alternative to ferric hydroxide (FH) in this setting. Aim To compare the therapeutic response to FH and FGS in children and adolescents with AIG-associated IDA. Methods We conducted a retrospective observational cohort study including pediatric patients diagnosed with AIG-associated IDA and followed at a tertiary Pediatric Gastroenterology Unit between 2007 and 2023. Treatment non-response was defined as a hemoglobin (Hb) increase Results Thirty-two patients were included (71% female; median age 12 years). IDA was the presenting feature in 94% of cases. Median baseline Hb was 9.8 g/dL and ferritin was 5 ng/mL. Thirty patients had previously received FH, of whom only four achieved an adequate response. The remaining 26 patients showed minimal improvement in Hb and ferritin and were subsequently switched to FGS. After switching, a significant increase in Hb and ferritin was observed (both p Conclusions In this retrospective cohort, FGS was associated with substantial hematologic improvement in pediatric patients with AIG-associated IDA, particularly in those who had failed previous FH therapy.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。